<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04955925</url>
  </required_header>
  <id_info>
    <org_study_id>03-2020</org_study_id>
    <nct_id>NCT04955925</nct_id>
  </id_info>
  <brief_title>Effect of Sevoflurane and Propofol on the Optic Nerve Sheath Diameter</brief_title>
  <official_title>Comparison of the Effect of Sevoflurane and Propofol on the Optic Nerve Sheath Diameter in Patients Undergoing Middle Ear Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>SMG-SNU Boramae Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>SMG-SNU Boramae Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the present study, we compare the effect of sevoflurane and propofol on the optic nerve&#xD;
      sheath diameter in patients undergoing middle ear surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 15, 2021</start_date>
  <completion_date type="Anticipated">October 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change of the optic nerve sheath diameter</measure>
    <time_frame>1 minute after the induction of anesthesia and 1 minute after the end of surgery</time_frame>
    <description>The optic nerve sheath of each eye is observed using ultrasound, and the optic nerve sheath diameter is assessed after induction of anesthesia and at the end of surgery.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Nausea and vomiting</measure>
    <time_frame>At 1 and 24 hours after surgery</time_frame>
    <description>Presence and severity of nausea and vomiting is assessed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dizziness</measure>
    <time_frame>At 1 and 24 hours after surgery</time_frame>
    <description>Presence and severity of dizziness is assessed.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">78</enrollment>
  <condition>Optic Nerve Sheath Diameter</condition>
  <arm_group>
    <arm_group_label>Sevoflurane group</arm_group_label>
    <description>Anesthesia is maintained with sevoflurane during the surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Propofol group</arm_group_label>
    <description>Anesthesia is maintained with total venous anesthesia using propofol during the surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Ultrasound examination of the optic nerve sheath diameter</intervention_name>
    <description>The optic nerve sheath diameter is examined using ultrasonography.</description>
    <arm_group_label>Propofol group</arm_group_label>
    <arm_group_label>Sevoflurane group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing middle ear surgery under general anesthesia&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients undergoing middle ear surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of cerebrovascular diseases&#xD;
&#xD;
          -  Increased intracranial pressure&#xD;
&#xD;
          -  History of ophthalmic surgery or diseases&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>March 31, 2021</study_first_submitted>
  <study_first_submitted_qc>July 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 9, 2021</study_first_posted>
  <last_update_submitted>July 13, 2021</last_update_submitted>
  <last_update_submitted_qc>July 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>SMG-SNU Boramae Medical Center</investigator_affiliation>
    <investigator_full_name>Jin-Young Hwang</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

